390 related articles for article (PubMed ID: 10408177)
21. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Thyroid cancer: reports up to date and a review.
Takeichi N; Ezaki H; Dohi K
J Radiat Res; 1991 Mar; 32 Suppl():180-8. PubMed ID: 1762104
[TBL] [Abstract][Full Text] [Related]
22. Male breast cancer incidence among atomic bomb survivors.
Ron E; Ikeda T; Preston DL; Tokuoka S
J Natl Cancer Inst; 2005 Apr; 97(8):603-5. PubMed ID: 15840883
[TBL] [Abstract][Full Text] [Related]
23. Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74.
Tokunaga M; Norman JE; Asano M; Tokuoka S; Ezaki H; Nishimori I; Tsuji Y
J Natl Cancer Inst; 1979 Jun; 62(6):1347-59. PubMed ID: 286106
[TBL] [Abstract][Full Text] [Related]
24. Effects of radiation on the incidence of prostate cancer among Nagasaki atomic bomb survivors.
Kondo H; Soda M; Mine M; Yokota K
Cancer Sci; 2013 Oct; 104(10):1368-71. PubMed ID: 23859763
[TBL] [Abstract][Full Text] [Related]
25. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
26. High Initial-dose Dependency of Cerebrovascular Disease Mortality among Female Survivors of the Hiroshima Atomic Bomb Exposed in Teens: A Cohort Study, 1970-2010.
Matsuba J; Otani K; Satoh K; Kawakami H; Ohtaki M
Hiroshima J Med Sci; 2016 Sep; 65(2):35-43. PubMed ID: 29989683
[TBL] [Abstract][Full Text] [Related]
27. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
[TBL] [Abstract][Full Text] [Related]
28. Radiation risk of central nervous system tumors in the Life Span Study of atomic bomb survivors, 1958-2009.
Brenner AV; Sugiyama H; Preston DL; Sakata R; French B; Sadakane A; Cahoon EK; Utada M; Mabuchi K; Ozasa K
Eur J Epidemiol; 2020 Jun; 35(6):591-600. PubMed ID: 31982981
[TBL] [Abstract][Full Text] [Related]
29. Psychiatric sequelae in atomic bomb survivors in Hiroshima and Nagasaki two decades after the explosions.
Yamada M; Izumi S
Soc Psychiatry Psychiatr Epidemiol; 2002 Sep; 37(9):409-15. PubMed ID: 12242616
[TBL] [Abstract][Full Text] [Related]
30. Parathyroid tumors in atomic bomb survivors in Hiroshima: first report of surgical cases, 1956-1988.
Takeichi N; Dohi K; Ito H; Hara H; Usui T; Yokoro K
Hiroshima J Med Sci; 1991 Jun; 40(2):75-7. PubMed ID: 1917558
[TBL] [Abstract][Full Text] [Related]
31. Incidence of Diabetes in the Atomic Bomb Survivors: 1969-2015.
Tatsukawa Y; Cordova K; Yamada M; Ohishi W; Imaizumi M; Hida A; Sposto R; Sakata R; Fujiwara S; Nakanishi S; Yoneda M
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2148-e2155. PubMed ID: 34918116
[TBL] [Abstract][Full Text] [Related]
32. Multiple primary cancers: with reference to atomic bomb survivors in Hiroshima.
Nakatsuka H; Nishiki M; Kuroda Y; Ezaki H
Jpn J Surg; 1983 Sep; 13(5):426-30. PubMed ID: 6668778
[TBL] [Abstract][Full Text] [Related]
33. Exposure to ionizing radiation and development of bone sarcoma: new insights based on atomic-bomb survivors of Hiroshima and Nagasaki.
Samartzis D; Nishi N; Hayashi M; Cologne J; Cullings HM; Kodama K; Miles EF; Funamoto S; Suyama A; Soda M; Kasagi F
J Bone Joint Surg Am; 2011 Jun; 93(11):1008-15. PubMed ID: 21984980
[TBL] [Abstract][Full Text] [Related]
34. Salivary gland tumors in atomic bomb survivors, hiroshima, japan. II. Pathologic study and supplementary epidemiologic observations.
Takeichi N; Hirose F; Yamamoto H; Ezaki H; Fujikura T
Cancer; 1983 Jul; 52(2):377-85. PubMed ID: 6305475
[TBL] [Abstract][Full Text] [Related]
35. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Cancer risk among in utero-exposed survivors.
Yoshimoto Y; Kato H; Schull WJ
J Radiat Res; 1991 Mar; 32 Suppl():231-8. PubMed ID: 1762110
[TBL] [Abstract][Full Text] [Related]
36. Workshop Report on Atomic Bomb Dosimetry--Review of Dose Related Factors for the Evaluation of Exposures to Residual Radiation at Hiroshima and Nagasaki.
Kerr GD; Egbert SD; Al-Nabulsi I; Bailiff IK; Beck HL; Belukha IG; Cockayne JE; Cullings HM; Eckerman KF; Granovskaya E; Grant EJ; Hoshi M; Kaul DC; Kryuchkov V; Mannis D; Ohtaki M; Otani K; Shinkarev S; Simon SL; Spriggs GD; Stepanenko VF; Stricklin D; Weiss JF; Weitz RL; Woda C; Worthington PR; Yamamoto K; Young RW
Health Phys; 2015 Dec; 109(6):582-600. PubMed ID: 26509626
[TBL] [Abstract][Full Text] [Related]
37. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Tumor registries and cancer incidence studies.
Mabuchi K; Soda M
J Radiat Res; 1991 Mar; 32 Suppl():239-44. PubMed ID: 1762111
[TBL] [Abstract][Full Text] [Related]
38. Malignancies in atomic bomb survivors in Hiroshima and Nagasaki.
Shimaoka K; Akiba S
J Nucl Med Allied Sci; 1990; 34(4):254-9. PubMed ID: 2090789
[No Abstract] [Full Text] [Related]
39. Monitoring exposure to atomic bomb radiation by somatic mutation.
Akiyama M; Kyoizumi S; Kusunoki Y; Hirai Y; Tanabe K; Cologne JB
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):493-6. PubMed ID: 8781371
[TBL] [Abstract][Full Text] [Related]
40. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
Ron E; Preston DL; Mabuchi K; Thompson DE; Soda M
Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
